You are here: Industry Insights > Market News > Zydus’ Nesher Pharma gets final USFDA nod for Lovaza capsules

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Riociguat(625115-55-1)

Methyl [4,6-diaMino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidin-5-yl]carbaMate

2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidine-4,5,6-triaMine(428854-24-4)

4,6-PyriMidinediaMine, 2-[1-[(2-fluorophenyl)Methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-(phenylazo)-

1H-Pyrazolo[3,4-b]pyridine-3-carboximidamide, 1-[(2-fluorophenyl)methyl]-, hydrochloride (1:1)

1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide(256376-68-8)

Zydus’ Nesher Pharma gets final USFDA nod for Lovaza capsules

biospectrumasiaJune 18, 2019

Tag: Zydus , Nesher Pharma , USFDA

Favorites

Zydus’ Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received the final approval from the USFDA to market Omega-3-Acid Ethyl Esters Capsules USP (US RLD – Lovaza Capsules), 1 gram. Omega-3 acid ethyl esters, a type of fat found in fish oil, is used along with diet and exercise to help lower levels of a certain blood fat (triglyceride). It may also raise good cholesterol (HDL).

The drug will be manufactured at Nesher Pharmaceuticals’ manufacturing facility located at St. Louis, MO, USA. The group now has 267 approvals and has so far filed over 360 ANDAs since the commencement of the filing process in FY 2003-04.

Previous:MEDICREA secures several new patents to protect UNiD ASI

Next:Need better collaboration to eliminate Malaria in Asia

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

Innovent Biologics announced that China's National Medical Products Administration (NMPA) has approved a New Drug Application (NDA) of DOVBLERON ® .

Zydus’ Nesher Pharma gets final USFDA nod for Lovaza capsules

Related News

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

Macrogen Consortium win tender for National Bio Big Data Project

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore

You may like
More>>

Zydus’ Nesher Pharma gets final USFDA nod for Lovaza capsules

Related News

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

Macrogen Consortium win tender for National Bio Big Data Project

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore

You may likeMore>>

You may like
More>>